Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Vegard Nygaard"'
Autor:
Timothy J. Lavelle, Tine Norman Alver, Karen-Marie Heintz, Patrik Wernhoff, Vegard Nygaard, Sigve Nakken, Geir Frode Øy, Sigurd Leinæs Bøe, Alfonso Urbanucci, Eivind Hovig
Publikováno v:
Cancers, Vol 12, Iss 7, p 1719 (2020)
The MC1R/cAMP/MITF pathway is a key determinant for growth, differentiation, and survival of melanocytes and melanoma. MITF-M is the melanocyte-specific isoform of Microphthalmia-associated Transcription Factor (MITF) in human melanoma. Here we use t
Externí odkaz:
https://doaj.org/article/21cfec50e8fd456fa1b5cc42dd3b4a85
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
The IL-17-producing CD4+ T helper cell (Th17) differentiation is affected by stimulation of the aryl hydrocarbon receptor (AhR) pathway and by hypoxia-inducible factor 1 alpha (HIF-1α). In some cases, Th17 become non-pathogenic and produce IL-10. Ho
Externí odkaz:
https://doaj.org/article/2c39a16808ff42b3935219a95503e135
Autor:
Elena Falcettoni, Vegard Nygaard
Publikováno v:
Finance and Economics Discussion Series. :1-66
We use an expected utility model to examine how living standards, or welfare, vary across the U.S. and how each state’s welfare has evolved over time. Our welfare measure accounts for cross-state variations in mortality, consumption, education, lei
Autor:
Gunhild M. Mælandsmo, Kjersti Flatmark, Anne-Lise Børresen-Dale, Anne Negård, Klaus Beiske, Eivind Hovig, Inger Riise Bergheim, Christin Johansen, Vegard Nygaard, Daniel Heinrich, Hege G. Russnes, Vigdis Nygaard, Anne Hansen Ree
Supplementary Table S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b758817d7f2a1a83fcd6ff4a7bfae74
https://doi.org/10.1158/2326-6066.22542465.v1
https://doi.org/10.1158/2326-6066.22542465.v1
Autor:
Gunhild M. Mælandsmo, Kjersti Flatmark, Anne-Lise Børresen-Dale, Anne Negård, Klaus Beiske, Eivind Hovig, Inger Riise Bergheim, Christin Johansen, Vegard Nygaard, Daniel Heinrich, Hege G. Russnes, Vigdis Nygaard, Anne Hansen Ree
Suppl Data incl Figure S1 and Table S3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a1b05e1bf118133b7bca3fe231b3e11
https://doi.org/10.1158/2326-6066.22542471.v1
https://doi.org/10.1158/2326-6066.22542471.v1
Autor:
Gunhild M. Mælandsmo, Kjersti Flatmark, Anne-Lise Børresen-Dale, Anne Negård, Klaus Beiske, Eivind Hovig, Inger Riise Bergheim, Christin Johansen, Vegard Nygaard, Daniel Heinrich, Hege G. Russnes, Vigdis Nygaard, Anne Hansen Ree
Most patients whose large bowel cancer has spread to other organs do not respond to immune therapy. We detected a rare gene mutation, termed 9p24.1 copy-number gain (CNG), in an otherwise incurable colorectal cancer that provoked an immune therapy re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23c1e69852bf376602cec7f6506dd887
https://doi.org/10.1158/2326-6066.c.6549936.v1
https://doi.org/10.1158/2326-6066.c.6549936.v1
Publikováno v:
Acta Paediatrica. 109:2636-2640
Aim The aim was to identify genetic variants associated with sudden infant death syndrome (SIDS) that can cause disease or introduce vulnerability. Genes reported in a previous SIDS study to have altered messenger ribonucleic acid (mRNA) expression i
Autor:
Vessela N. Kristensen, Gry A. Geitvik, Christin Johansen, Kjetil Boye, Eivind Hovig, Sigve Nakken, Anne Hansen Ree, Gunhild Mari Mælandsmo, Daniel Heinrich, Vigdis Nygaard, Ole Christian Lingjærde, Svein Dueland, Vivi Ann Flørenes, Anne Negård, Anne Lise Børresen-Dale, Lars Julsrud, Claudius H Reisse, Vegard Nygaard, Salah Nasser, Hege G. Russnes, Klaus Beiske, Kjersti Flatmark, Inger Riise Bergheim, Marius Lund-Iversen, Espen A. Ruud
Background: In precision cancer medicine, the challenge is to prioritize DNA driver events, account for resistance markers, and procure sufficient information for treatment that maintains patient safety. The MetAction project, exploring how tumor mol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70ffea2a9af6ed559a75c4a2b4aee573
https://hdl.handle.net/10037/18698
https://hdl.handle.net/10037/18698
Autor:
Elisabeth Dybing, Marte Fauskanger, Nina Therese Solberg, Aleksandra Aizenshtadt, Eivind Hovig, Jo Waaler, Anders Aune Tveita, Martin Frank Strand, Shoshy Alam Brinch, Clara Hammarström, Max Lycke, Karen-Marie Heintz, Alexandre Corthay, Petter Angell Olsen, Vegard Nygaard, Kaja Lund, Sigurd Laeines Boe, Line Mygland, Stefan Krauss
Publikováno v:
Communications Biology
Communications Biology, Vol 3, Iss 1, Pp 1-13 (2020)
Communications Biology, Vol 3, Iss 1, Pp 1-13 (2020)
The development of immune checkpoint inhibitors represents a major breakthrough in cancer therapy. Nevertheless, a substantial number of patients fail to respond to checkpoint pathway blockade. Evidence for WNT/β-catenin signaling-mediated immune ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f2c3da10a77bd13965cbd251ff5323e
http://hdl.handle.net/10852/83116
http://hdl.handle.net/10852/83116